The goal of this study is to determine the safety of the vaccine and measure how strongly it triggers the body’s immune response to COVID-19.
This is a recombinant vaccine, so you will not be exposed to Coronavirus / COVID-19 by taking part in this study.
Participants in this research are reimbursed $2,450 for their time and this clinical trial has been approved by an independent ethics committee.
You must be able to attend 8 outpatient visits at our facility in Melbourne. You are not required to stay overnight at our facility, and there is some flexibility in the dates of the outpatient visits.
Take a short quiz to see if you’re eligible!
Private TV Per Bed
Free Catered Food